NCT07127315View on ClinicalTrials.gov

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

July 1, 2024

Conditions
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausalBreast CancerChemotherapy
Interventions
DRUG

Gonadotropin-releasing hormone agonist

Patients received chemotherapy plus a gonadotropin-releasing hormone agonist.

DRUG

Chemotherapy

Patients received chemotherapy alone.

Trial Locations (1)

11795

Helwan University, Helwan

All Listed Sponsors
lead

Helwan University

OTHER